Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Cytomed
New Taipei City, Taiwanbio-cytomed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bio-Cytomed is a biotechnology company based in Taiwan that specializes in the development and commercialization of regenerative medicine products. The company focuses on utilizing its proprietary extracellular matrix (ECM) technology to create scaffolds and bioactive materials for tissue engineering and wound management. Their product portfolio includes solutions for chronic wound healing, orthopedic applications such as cartilage repair, and dental regeneration. Bio-Cytomed aims to provide advanced clinical solutions that accelerate the body's natural healing processes through biocompatible and bioactive medical devices.
- Therapeutic areas
- OtherRheumatologyDermatology
- Modalities
- Cell therapyBiologicDevice
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Bio-Cytomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Cytomed.